Recursion Pharmaceuticals Inc vs J M Smucker Co — how do they compare? Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B), while J M Smucker Co trades at $112.69 (market cap $11.97B). The key difference: J M Smucker Co is far larger — about 7.8× Recursion Pharmaceuticals Inc's market cap, and J M Smucker Co pays a 3.93% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| RXRX | SJM | |
|---|---|---|
Market Cap | $1.53B | $11.97B |
Sector | Health | Consumer Staples |
52-Week High | $6.79 | $117.05 |
52-Week Low | $2.84 | $89.53 |
Enterprise Value | $946.50M | $19.00B |
Dividend Yield | — | 3.93% |
Trailing returns across standard periods
Latest headlines on both assets
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →J.M. Smucker is a packaged food company that primarily operates in the U.S. retail channel (87% of fiscal 2022 revenue), but also in U.S. food-service (7%), and international (6%). Its largest segment is pet food and treats (36% of 2022 revenue), with popular brands such as Milk-Bone, Meow Mix, 9Lives, Kibbles 'n Bits, Nature's Recipe, and Rachael Ray Nutrish. Its second-largest category is coffee (35% across channels) with the number-two brand Folgers and number-six Dunkin'. Other large categories are peanut butter (10%), with number-one Jif, fruit spreads (5%) with number-one Smucker's, and frozen hand-held foods (6%) with number-one Uncrustables.
Read more on SJM →